Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Multi-Modality Tumor Tracking (MMTT) application

K-Number: K162955 · 2016-12-19

ApplicantPhilips Medical Systems Nederland B.V.
Decision Date2016-12-19
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Multi-Modality Tumor Tracking (MMTT) application is a medical device manufactured by Philips Medical Systems Nederland B.V.. It received FDA 510(k) clearance on 2016-12-19 under approval number K162955. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Multi-Modality Tumor Tracking (MMTT) application?

Multi-Modality Tumor Tracking (MMTT) application is a medical device that received FDA 510(k) clearance on 2016-12-19. It is manufactured by Philips Medical Systems Nederland B.V.. The 510(k) number is K162955.

When was Multi-Modality Tumor Tracking (MMTT) application approved by the FDA?

Multi-Modality Tumor Tracking (MMTT) application received FDA 510(k) clearance on 2016-12-19, under approval number K162955.

What company makes Multi-Modality Tumor Tracking (MMTT) application?

Multi-Modality Tumor Tracking (MMTT) application is manufactured by Philips Medical Systems Nederland B.V..

What is the FDA product code for Multi-Modality Tumor Tracking (MMTT) application?

The FDA product code for Multi-Modality Tumor Tracking (MMTT) application is LLZ.

Related Clinical Trials

NCT07195591 Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care RECRUITING NCT07464275 Performance Assessment of the MAGENTA Blast Algorithm for Embryo Prediction COMPLETED NCT07385508 Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches RECRUITING NCT07600840 Integrating Smart Wearable Device Into Digital Insomnia Treatment Application: Exploration of Combining Emotional and Lifestyle Records ENROLLING_BY_INVITATION NCT07373496 Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper Abdomen RECRUITING NCT07593365 Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain NOT_YET_RECRUITING

Related PubMed Literature

PMID: 42145202 Fertile-window misclassification in period-tracking applications and associated pregnancy risk: a large observational analysis. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2026) PMID: 41116086 Eye-tracking-based tablet application for enhanced cognitive assessment: a clinical trial for software as a medical device (SaMD). GeroScience (2025)

Other Devices by Philips Medical Systems Nederland B.V.

K162940MultiBand SENSE K162859Allura Xper FD series and Allura Xper OR Table series K160455AneurysmFlow K160147CT TrueView K1618392D Quantitative Analysis K161563Allura Xper FD series and Allura Xper OR Table series

View all 77 devices →

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC K152009DENSEEMAMMO v1.0Statlife

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑